Fewer cancers.
Better survival.
Equity for all.

Recent changes in the last 30 days:

New regimens

• LYM HL Classic Advanced - escBEACOPP [bleomycin, etoposide, DOXOrubicin, CYCLOPHOSPHamide, vinCRISTine, prEDNISone and procarbazine] interim PET-guided [under 60 years]

Updated regimens

• CRC Adjuvant - CAPOX [capecitabine and oxaliplatin]

• CRC Adjuvant - MAYO [foliNIc acid and fluorouracil]

• CRC Adjuvant - mDe Gramont [foliNIc acid and fluorouracil] [high dose foliNIc acid]

• CRC Adjuvant - mDe Gramont [foliNIc acid and fluorouracil] [low dose foliNIc acid]

• CRC Adjuvant - mFOLFOX6 [oxaliplatin, foliNIc acid and fluorouracil] [high dose foliNIc acid]

• CRC Adjuvant - mFOLFOX6 [oxaliplatin, foliNIc acid and fluorouracil] [low dose foliNIc acid]

• CRC Adjuvant - mQUASAR [foliNIc acid and fluorouracil]

• CRC Adjuvant - mRoswell Park [foliNIc acid and fluorouracil] [high dose foliNIc acid]

• CRC Adjuvant - mRoswell Park [foliNIc acid and fluorouracil] [low dose foliNIc acid]

• CRC Metastatic - CAPOX [capecitabine and oxaliplatin]

• CRC Metastatic - CAPOX [capecitabine and oxaliplatin] and beVACizumab

• CRC Metastatic - FLOX [oxaliplatin, foliNIc acid and fluorouracil]

• CRC Metastatic - IrOX [oxaliplatin and irinotecan]

• CRC Metastatic - mCAPIRI [irinotecan and capecitabine]

• CRC Metastatic - mDe Gramont [foliNIc acid and fluorouracil] [high dose foliNIc acid]

• CRC Metastatic - mDe Gramont [foliNIc acid and fluorouracil] [low dose foliNIc acid]

• CRC Metastatic - mFOLFIRI [irinotecan, foliNIc acid fluorouracil] and CETUximab [Q2W] [low dose foliNIc acid]

• CRC Metastatic - mFOLFIRI [irinotecan, foliNIc acid and fluorouracil] [high dose foliNIc acid]

• CRC Metastatic - mFOLFIRI [irinotecan, foliNIc acid and fluorouracil] [low dose foliNIc acid]

• CRC Metastatic - mFOLFIRI [irinotecan, foliNIc acid and fluorouracil] and beVACizumab [high dose foliNIc acid]

• CRC Metastatic - mFOLFIRI [irinotecan, foliNIc acid and fluorouracil] and beVACizumab [low dose foliNIc acid]

• CRC Metastatic - mFOLFIRI [irinotecan, foliNIc acid fluorouracil] and CETUximab [Q2W] [high dose foliNIc acid]

• CRC Metastatic - mFOLFOX6 [oxaliplatin, foliNIc acid and fluorouracil] and CETUximab [Q2W] [low dose foliNIc acid]

• CRC Metastatic - mFOLFOX6 [oxaliplatin, foliNIc acid and fluorouracil] [high dose foliNIc acid]

• CRC Metastatic - mFOLFOX6 [oxaliplatin, foliNIc acid and fluorouracil] [low dose foliNIc acid]

• CRC Metastatic - mFOLFOX6 [oxaliplatin, foliNIc acid and fluorouracil] and beVACizumab [high dose foliNIc acid]

• CRC Metastatic - mFOLFOX6 [oxaliplatin, foliNIc acid and fluorouracil] and beVACizumab [low dose foliNIc acid]

• CRC Metastatic - mFOLFOX6 [oxaliplatin, foliNIc acid and fluorouracil] and CETUximab [Q2W] [high dose foliNIc acid]

• CRC Metastatic - mFOLFOXIRI [irinotecan, oxaliplatin, foliNIc acid and fluorouracil] [high dose foliNIc acid]

• CRC Metastatic - mFOLFOXIRI [irinotecan, oxaliplatin, foliNIc acid and fluorouracil] [low dose foliNIc acid]

• CRC Metastatic - mFOLFOXIRI [irinotecan, oxaliplatin, foliNIc acid and fluorouracil] with beVACizumab [high dose foliNIc acid]

• CRC Metastatic - mFOLFOXIRI [irinotecan, oxaliplatin, foliNIc acid and fluorouracil] with beVACizumab [low dose foliNIc acid]

• CRC Metastatic - mQUASAR [foliNIc acid and fluorouracil]

• CRC Metastatic - mRoswell Park [foliNIc acid and fluorouracil] [high dose foliNIc acid]

• CRC Metastatic - mRoswell Park [foliNIc acid and fluorouracil] [low dose foliNIc acid]

• HN SQCC NON-Metastatic - cISplatin [Q1W] chemoradiation

• HN SQCC NON-Metastatic - cISplatin [Q1W] post-operative chemoradiation

• UGI GAST Adjuvant - fluorouracil chemoradiation [modified MacDonald]

Superseded regimens

No recent superseded regimens

Discontinued regimens

No recent discontinued regimens

Regimens taken offline

No regimens taken offline recently